Kestra Medical Technologies, maker of wearable cardiac devices, files for IPO
Kestra Medical Technologies, a Kirkland-based company selling cardiac monitoring and therapeutic devices, filed for an initial public offering on Monday.
Kestra launched in 2014 and makes wearable devices to detect and respond to sudden cardiac arrest, which is responsible for 475,000 deaths each year in the U.S. The company has raised $496 million from investors, including a $196 million round in July.
Kestra’s filing for initial public offering underscores the growth of Washington’s life sciences industry, particularly in the development of innovative medical devices.
Pictured: Brian Webster, President and CEO of Kestra Medical Technologies.